Wednesday, December 19, 2018 4:05:52 PM
Here was the response from Vivos on the Dart treatment I found recently.
Me: I recently found this. How does this affect things? Are you all worried about something like this getting to market and human trials first? I know it is a different isotope. Can you tell me how this differs from RadioGel? Thanks and keep up the amazing with guys.
https://bit.ly/2BoUYG0
Vivos: Hi William. Quite different technology than ours. Alpha packs a big punch, but can also do lots of critical damage to adjacent cells. This may have results fighting a blood cancer. Using term minimally invasive here is a total stretch of the truth.
Tumors are still best treated with a Beta Emitter such as our Yttrium-90. If it’s one thing Dr. Korenko knows more than most is the various type of isotopes, their safety, and what they are useful for.
Merry Christmas.
Me: I recently found this. How does this affect things? Are you all worried about something like this getting to market and human trials first? I know it is a different isotope. Can you tell me how this differs from RadioGel? Thanks and keep up the amazing with guys.
https://bit.ly/2BoUYG0
Vivos: Hi William. Quite different technology than ours. Alpha packs a big punch, but can also do lots of critical damage to adjacent cells. This may have results fighting a blood cancer. Using term minimally invasive here is a total stretch of the truth.
Tumors are still best treated with a Beta Emitter such as our Yttrium-90. If it’s one thing Dr. Korenko knows more than most is the various type of isotopes, their safety, and what they are useful for.
Merry Christmas.
Recent RDGL News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:45:22 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 08:44:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
